The Board of Directors of Pharmaniaga Berhad (“the Company”) wishes to announce that Pharmaniaga Berhad (“PB”) has on 31 October 2022 entered into a Memorandum of Understanding (“MOU”) with JDMAS Commerce Sdn. Bhd. to establish a basis of co-operation and collaboration between the Parties for the purpose of registering, importing, distributing and marketing of PHARMANIAGA’s over the counter products (OTC) and generic pharmaceutical product into China market through the digital e-commerce platform, JD.com (“the Collaboration”).
Please refer to the attachment for details of the announcement.
This announcement is dated 31 October 2022.